Scancell Holdings Share Price | |
---|---|
Price | 9.15 |
Bid | 8.80 |
Ask | 9.50 |
Change | 0.05 (0.55%) |
Volume | 1,054,095 |
Open | 9.10 |
High | 9.15 |
Low | 8.70 |
Prev. Close | 9.10 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 928.98m |
Market Capitalisation | £85.00m |
Market Size | 30,000 |
52 Week High | 17.375 |
52 Week High Date | 20-Sep-2023 |
52 Week Low | 7.65 |
52 Week Low Date | 05-Sep-2023 |
# Trades | 42 |
---|---|
Vol. Sold | 242,053 |
Sold Value | £21.30k |
Vol. Bought | 278,030 |
Bought Value | £25.63k |
PE Ratio | -6.102441 |
Earnings | -1.4994 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 17:07:32 | 9.15 | 200,000 | Unknown* | 8.80 | 9.50 | 18.30k | O Ordinary Was reported as OTC |
03-May-24 | 15:57:00 | 9.25 | 100,000 | Buy* | 8.80 | 9.50 | 9,250 | O Ordinary |
03-May-24 | 15:13:55 | 9.22 | 40,043 | Buy* | 8.80 | 9.50 | 3,692 | O Ordinary |
03-May-24 | 14:43:55 | 9.22 | 10,000 | Buy* | 8.80 | 9.50 | 922.00 | O Ordinary |
03-May-24 | 14:19:52 | 9.06 | 12,000 | Sell* | 8.80 | 9.50 | 1,087 | O Ordinary |
03-May-24 | 14:11:55 | 9.06 | 300 | Sell* | 8.80 | 9.50 | 27.18 | O Ordinary |
03-May-24 | 14:11:41 | 9.06 | 400 | Sell* | 8.80 | 9.50 | 36.24 | O Ordinary |
03-May-24 | 13:59:32 | 9.22 | 10,444 | Buy* | 8.80 | 9.50 | 962.94 | O Ordinary |
03-May-24 | 13:10:29 | 9.22 | 6,464 | Buy* | 8.80 | 9.50 | 595.98 | O Ordinary |
03-May-24 | 13:01:33 | 9.185 | 100,000 | Buy* | 8.80 | 9.50 | 9,185 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
06-Dec-23 | 05-Dec-23 | Buy | Jean-Michel Cosséry held the position of Non-Executive Chairman at the time of this trade.Jean-Michel Cosséry | 11.00 | GBX | 454,545 | 454,545 |
06-Dec-23 | 05-Dec-23 | Buy | Lindy Durrant held the position of CEO at the time of this trade.Lindy Durrant | 11.00 | GBX | 272,727 | 272,727 |
03-Mar-22 | 02-Mar-22 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 12.00 | GBX | 250,000 | 117,729,029 |
03-Nov-21 | 02-Nov-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 200,000 | 118,479,029 |
02-Nov-21 | 29-Oct-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 100,000 | 118,279,029 |
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.